862845-69-0 Usage
Uses
Used in Pharmaceutical Industry:
BENZAMIDE, N-[7-(CHLOROMETHYL)-1-ISOQUINOLINYL]is used as a chemical intermediate for the synthesis of pharmaceuticals. Its unique structure allows it to be incorporated into the development of new drugs, potentially offering novel therapeutic options for various medical conditions.
Used in Agrochemical Industry:
In the agrochemical sector, BENZAMIDE, N-[7-(CHLOROMETHYL)-1-ISOQUINOLINYL]serves as an intermediate in the production of agrochemicals. Its properties can be leveraged to create compounds that address specific needs in agriculture, such as pest control or crop protection, thereby contributing to more efficient and sustainable farming practices.
The specific applications of BENZAMIDE, N-[7-(CHLOROMETHYL)-1-ISOQUINOLINYL]in these industries may vary, as its uses are determined by the requirements of the particular chemical reactions and end products being developed. Its versatility as a chemical intermediate positions it as a valuable component in the creation of a wide range of substances across different fields.
Check Digit Verification of cas no
The CAS Registry Mumber 862845-69-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,8,4 and 5 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 862845-69:
(8*8)+(7*6)+(6*2)+(5*8)+(4*4)+(3*5)+(2*6)+(1*9)=210
210 % 10 = 0
So 862845-69-0 is a valid CAS Registry Number.
InChI:InChI=1S/C17H13ClN2O/c18-11-12-6-7-13-8-9-19-16(15(13)10-12)20-17(21)14-4-2-1-3-5-14/h1-10H,11H2,(H,19,20,21)
862845-69-0Relevant academic research and scientific papers
Design, synthesis and testing of amino-bicycloaryl based orally bioavailable thrombin inhibitors
Rewinkel,Lucas,Smit,Noach,Van Dinther,Rood,Jenneboer,Van Boeckel
, p. 2837 - 2842 (2007/10/03)
Replacement of the highly basic benzamidine moiety with moderate basic amino-bicycloaryl moieties in a series of thrombin inhibitors related to NAPAMP provided potent enzyme inhibition and significant improvements in membrane transport and oral bioavailability.
